Cargando…
Correction: An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics
Correction for ‘An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics’ by Elesha R. Hoffarth et al., Chem. Sci., 2021, 12, 8817–8821, DOI: 10.1039/D0SC05843B.
Autores principales: | Hoffarth, Elesha R., Kong, Sunnie, He, Hai-Yan, Ryan, Katherine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442674/ https://www.ncbi.nlm.nih.gov/pubmed/34659732 http://dx.doi.org/10.1039/d1sc90180j |
Ejemplares similares
-
An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics
por: Hoffarth, Elesha R., et al.
Publicado: (2021) -
Correction: Synthetic routes for a variety of halogenated (chiral) acetic acids from diethyl malonate
por: Mazenauer, Manuel R., et al.
Publicado: (2018) -
Post-synthetic halide conversion and selective halogen capture in hybrid perovskites
por: Solis-Ibarra, D., et al.
Publicado: (2015) -
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering
por: Groß, Sebastian, et al.
Publicado: (2021) -
Production of the Bioactive Compounds Violacein and Indolmycin Is Conditional in a maeA Mutant of Pseudoalteromonas luteoviolacea S4054 Lacking the Malic Enzyme
por: Thøgersen, Mariane S., et al.
Publicado: (2016)